{"ticker": {"uuid": "ea12c11b-3fcf-4c39-a6ae-7813fb5eba9a", "symbol": "302440", "name": "SK bioscience Co.,Ltd.", "exchange": "KSC", "country": "KR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "SK Bioscience stock trades steady as vaccine revenue supports margins", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOVDltU0tqUDJCRmNmMUFOOHNROEhicTF4ZVFkWXhmYnIxZlMySktodnl5MzVpQVk3YUhPM2RsNXJlaHRJRHRtZWl6clJOakxwSVdnY3hPZnYtWjBmcl9YamFjTnRrTG5XVjlxTG9TNGJGOExMYTZ3MkFUV0RUTkxqcnB2RUJrOW1LTE04d2lra1d6UG1GTzlvVWdrSHp4U00wNDM4WGxlSllpRVhjTDZ6eTJDNUEyU21zaklMLVh2SzZlVTlEYjhN?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-16T19:45:32+00:00", "published_display": "16 Jul 2026 19:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sky Cell Flu from SK Bioscience - Korea\u2019s leading cell-based influenza shot", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQZ21xd0M0RXhLeW0ybGdJTExmNEJnZnZwUjNPY2JMOW5UUkZFVkFUVFp0bldkMjJfMFRMX0ExeWpWTDg4dDkwRXM3b3diem9DM1BCZk1JaUU5YzJQNGNGTWVSTVZoME5oRV9VaXp5WjBfU2RIY3dUN3Y5cktpQTRMc2lvSWt5TWV2enhhTjlfNUxmS29VM1FXLXNSNEJiZTdFX3pxUkxoX2lqZEswY2liUnJCM3Q4ZFR2d2lNVEFHU0MxUnpZRkE?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-06T22:52:43+00:00", "published_display": "06 Jul 2026 22:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Bioscience outlines vaccine growth strategy as biotech interest stays high", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQeEo2cGVFTktwZ1p6a0piTXBZemIyRkpwYlNybHd1d1pfQllJTUcyZWNtOHM1QWx3THRJcVVYZ1N4V2xRMk40Ymg3SjVDUENvZTdkVkJGSEJ1SDhZN1pldW9qMGpHSUpXUnNHcXUycW1KWEVERGlfbnNYcnJzcWZwWVJ5Qi1TVjZEWUxyMFpaTi1KZkJjM0FLN1M3dm5vOEVxbzFMVm56OVNhdEU1SjltUHFId3VjdUdGalBHV1J4djlnei1lN0dNMmVsVQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T17:56:57+00:00", "published_display": "04 Jul 2026 17:56", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Bioscience outlines long-term vaccine strategy as a Korean biotech player builds global partnersh", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQV2FIUWM4Nl9RNmxDWVNKbTFaZEdRM2liMDZIazh1NWdvc2tZQjdhN3JlWjBtMjduNnlhYmJ5RUx3TElTR3p1cWl4SExuT3NWV3BlSTEwRENlMEVWbzVoYVUxYUhFN05QbzJsVU05MkotNkFYSVNKVEFrZ29vMFAtSk1CRzg2eFZhT0daTnNITENaSjhiX3hIclM2bVN5N1RYTHJzSmQyNU1kbVBkdWJOUDlrRU51NFQ1RE42a1dLZDR1U29saWtJ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T11:19:50+00:00", "published_display": "04 Jul 2026 11:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vaccine developer SK Bioscience to raise $1.3 bln in S.Korea's largest IPO since 2017", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPaEhUaFJ0b1pyU0QtLXRhblN4dmJTR0htdlV0bTV4Qy1VT1JRUXF6TjNFaFMyLWpoY0JvRjYxZ0p2eXJROC1zZ1A1LW5acjkycXBJWHV3VE9QSmlGaFBLNzN6NjNSdk50SlFkVWRpckgtNk1mZDltanVxWGxTcWNveHc1bWNDUTE4Mkd5aklRZUJHNWlmandCMEpZUmZmUUx2YWhqMlhfVUhZUzV5X0VvLUlYWFE5cnF2SDdOSFJDOENHWXdCM19F?oc=5", "source_name": "Reuters", "published_at": "2021-03-08T08:00:00+00:00", "published_display": "08 Mar 2021 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Bioscience\u2019s $1.3 bn IPO generates $10 mn in underwriting fees", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFAzOGNMeFBZY1NmNVQ3aUpvdjZhSURnRHNsMnpuZFV5RUhrbjhmcjZmU3Q2OUxrNG9EdFlNRllTSkRLcFNVaW5YWUpuSTVaREdkbl9JbUVCUEgwZUhDSFNQSkV4R21aUQ?oc=5", "source_name": "KED Global", "published_at": "2021-03-08T08:00:00+00:00", "published_display": "08 Mar 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Controversy surrounds SK Bioscience\u2019s $1 bn IPO valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE85bnplRS1RYm5TS3pwU0h2QUs3dFY0ZEhHVFc2RWpvTWx4WjBXZmx5UlV1eDJsYTAtQWxtallCZVduSHBXVWhtRXpIVjIxRDZlckdLaW54cU9VNGlJVmF4QTdXMXpzdw?oc=5", "source_name": "KED Global", "published_at": "2021-02-09T08:00:00+00:00", "published_display": "09 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "SK Bioscience stock trades steady as vaccine revenue supports margins", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOVDltU0tqUDJCRmNmMUFOOHNROEhicTF4ZVFkWXhmYnIxZlMySktodnl5MzVpQVk3YUhPM2RsNXJlaHRJRHRtZWl6clJOakxwSVdnY3hPZnYtWjBmcl9YamFjTnRrTG5XVjlxTG9TNGJGOExMYTZ3MkFUV0RUTkxqcnB2RUJrOW1LTE04d2lra1d6UG1GTzlvVWdrSHp4U00wNDM4WGxlSllpRVhjTDZ6eTJDNUEyU21zaklMLVh2SzZlVTlEYjhN?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-16T19:45:32+00:00", "published_display": "16 Jul 2026 19:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sky Cell Flu from SK Bioscience - Korea\u2019s leading cell-based influenza shot", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQZ21xd0M0RXhLeW0ybGdJTExmNEJnZnZwUjNPY2JMOW5UUkZFVkFUVFp0bldkMjJfMFRMX0ExeWpWTDg4dDkwRXM3b3diem9DM1BCZk1JaUU5YzJQNGNGTWVSTVZoME5oRV9VaXp5WjBfU2RIY3dUN3Y5cktpQTRMc2lvSWt5TWV2enhhTjlfNUxmS29VM1FXLXNSNEJiZTdFX3pxUkxoX2lqZEswY2liUnJCM3Q4ZFR2d2lNVEFHU0MxUnpZRkE?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-06T22:52:43+00:00", "published_display": "06 Jul 2026 22:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Bioscience outlines vaccine growth strategy as biotech interest stays high", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQeEo2cGVFTktwZ1p6a0piTXBZemIyRkpwYlNybHd1d1pfQllJTUcyZWNtOHM1QWx3THRJcVVYZ1N4V2xRMk40Ymg3SjVDUENvZTdkVkJGSEJ1SDhZN1pldW9qMGpHSUpXUnNHcXUycW1KWEVERGlfbnNYcnJzcWZwWVJ5Qi1TVjZEWUxyMFpaTi1KZkJjM0FLN1M3dm5vOEVxbzFMVm56OVNhdEU1SjltUHFId3VjdUdGalBHV1J4djlnei1lN0dNMmVsVQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T17:56:57+00:00", "published_display": "04 Jul 2026 17:56", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Bioscience outlines long-term vaccine strategy as a Korean biotech player builds global partnersh", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQV2FIUWM4Nl9RNmxDWVNKbTFaZEdRM2liMDZIazh1NWdvc2tZQjdhN3JlWjBtMjduNnlhYmJ5RUx3TElTR3p1cWl4SExuT3NWV3BlSTEwRENlMEVWbzVoYVUxYUhFN05QbzJsVU05MkotNkFYSVNKVEFrZ29vMFAtSk1CRzg2eFZhT0daTnNITENaSjhiX3hIclM2bVN5N1RYTHJzSmQyNU1kbVBkdWJOUDlrRU51NFQ1RE42a1dLZDR1U29saWtJ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-04T11:19:50+00:00", "published_display": "04 Jul 2026 11:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vaccine developer SK Bioscience to raise $1.3 bln in S.Korea's largest IPO since 2017", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPaEhUaFJ0b1pyU0QtLXRhblN4dmJTR0htdlV0bTV4Qy1VT1JRUXF6TjNFaFMyLWpoY0JvRjYxZ0p2eXJROC1zZ1A1LW5acjkycXBJWHV3VE9QSmlGaFBLNzN6NjNSdk50SlFkVWRpckgtNk1mZDltanVxWGxTcWNveHc1bWNDUTE4Mkd5aklRZUJHNWlmandCMEpZUmZmUUx2YWhqMlhfVUhZUzV5X0VvLUlYWFE5cnF2SDdOSFJDOENHWXdCM19F?oc=5", "source_name": "Reuters", "published_at": "2021-03-08T08:00:00+00:00", "published_display": "08 Mar 2021 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SK Bioscience\u2019s $1.3 bn IPO generates $10 mn in underwriting fees", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTFAzOGNMeFBZY1NmNVQ3aUpvdjZhSURnRHNsMnpuZFV5RUhrbjhmcjZmU3Q2OUxrNG9EdFlNRllTSkRLcFNVaW5YWUpuSTVaREdkbl9JbUVCUEgwZUhDSFNQSkV4R21aUQ?oc=5", "source_name": "KED Global", "published_at": "2021-03-08T08:00:00+00:00", "published_display": "08 Mar 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Controversy surrounds SK Bioscience\u2019s $1 bn IPO valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE85bnplRS1RYm5TS3pwU0h2QUs3dFY0ZEhHVFc2RWpvTWx4WjBXZmx5UlV1eDJsYTAtQWxtallCZVduSHBXVWhtRXpIVjIxRDZlckdLaW54cU9VNGlJVmF4QTdXMXpzdw?oc=5", "source_name": "KED Global", "published_at": "2021-02-09T08:00:00+00:00", "published_display": "09 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 60, "total_relevant": 7, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 5, "score": 55, "total": 7, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 3.65, "count": 6}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 36650.0, "latest_week": "2026-07-10", "one_week_move": -2.8, "four_week_move": -6.5, "twelve_week_move": -21.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.937402, "market_dynamics_buy_signal": false, "relative_strength": -52.165447, "fair_value_gap": -31.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.5733, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.8% over one week, -6.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "ad-hoc-news.de", "count": 4}, {"label": "KED Global", "count": 2}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 7}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "7", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.8% over one week, -6.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "SK Bioscience stock trades steady as vaccine revenue supports margins"}], "updated_at": "2026-07-18T08:48:50.201516+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}